Xinyuan Zhang - Publications

Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma.

Journal: Hepatology international

Published: November 14, 2022

Prognostic effect of albumin-to-alkaline phosphatase ratio on patients with hepatocellular carcinoma: a systematic review and meta-analysis.

Journal: Scientific reports

Published: September 07, 2022

Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: April 26, 2022

Complete Response After Pre-Operative Transcatheter Arterial Chemoembolization for Unresectable Primary Hepatic Neuroendocrine Tumour: A Case Report and Literature Review.

Journal: Frontiers in oncology

Published: March 10, 2022

Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablation.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: March 07, 2022

Association between depressive symptoms and lung function in the United States adults without pulmonary diseases: A cross-sectional study from NHANES.

Journal: Journal of affective disorders

Published: February 06, 2022

The effectiveness of radiofrequency ablation for patients with BCLC B1 stage hepatocellular carcinoma downgraded by transarterial chemoembolization.

Journal: Clinics and research in hepatology and gastroenterology

Published: December 22, 2021

Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study.

Journal: Journal of gastrointestinal oncology

Published: August 16, 2021

Prognostic significance of systemic immune-inflammation index-based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation.

Journal: Journal of gastrointestinal oncology

Published: May 20, 2021

Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study.

Journal: Journal of hepatocellular carcinoma

Published: April 09, 2021

A Systemic Inflammation Response Index (SIRI)-Based Nomogram for Predicting the Recurrence of Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.

Journal: Cardiovascular and interventional radiology

Published: March 26, 2021

Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factors.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: March 16, 2021